Mednax Inc Stock
Price
Target price
€18.10
€18.10
-1.630%
-0.3
-1.630%
€17.39
10.12.25 / Frankfurt
WKN: A0RELL / Symbol: MD / Name: MEDNAX / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Mednax Inc Stock
We can see a decrease in the price for Mednax Inc. Compared to yesterday it has lost -€0.300 (-1.630%).
Currently there is a rather positive sentiment for Mednax Inc with 4 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 17 € is below the current price of 18.1 € for Mednax Inc, so the potential is actually -6.08%.
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | -1.630% | -9.804% | -2.128% | 37.313% | 43.750% | 23.490% | -2.646% |
| Ensign Group Inc. | -1.320% | -2.597% | -4.459% | 11.111% | 18.110% | - | - |
| Amn Healthcare Svs | -0.740% | -4.895% | -8.725% | -46.457% | -40.351% | -87.748% | -75.495% |
| Chemed Corp. | 0.000% | -2.186% | -4.787% | -30.485% | -28.112% | - | - |
Comments
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) had its price target raised by analysts at Macquarie from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MD provided by MarketBeat